丝素/明胶共混膜的结构与溶解性能的初探

将丝素溶液与明胶溶液按不同共混比在不同条件下进行混合,制备成丝素/明胶共混膜。用环境扫描电镜、红外光谱仪、差示扫描量热分析系统分别测定共混膜的结构与热性能,采用烘干质量法测定共混膜的溶胀率和溶解率。结果表明:丝素与明胶的共混性好,共混膜结构改变,热稳定性好;烘干时间对共混膜的溶胀率和溶解率影响不显著,不同浓度乙醇处理对溶胀率有极显著影响,不同共混比则对溶胀率和溶解率都有极显著影响。     

AA肉鸡腿肌重活体估测方法的探讨

以AA肉鸡商品代为试验材料,分析0、7、14、21、28、35、42日龄公、母鸡整体和腿肌的累积生长,建立腿肌重(y)与活重(x)之间的直线回归、幂回归、指数回归、对数回归及多项式回归方程,探讨腿肌重的活体估测方法。结果表明,AA肉鸡的腿肌在后期生长迅速,尤其是公鸡在35～42日龄时期表现突出;腿肌重(y)与活重(x)的幂回归、直线回归、多项式回归方程的拟合精度均在0.95左右,效果较好。     

哈默教授眼中的中国养猪业

未来10年,中国动物蛋白的消费将成倍增长,而这种增长需要依靠高效率和高性能的生产得以实现。现代高效率养猪业依赖于学科的综合应用,这必将使养猪业经历一场技术革新,使得产品在产量、质量和生产效率等方面得到改善。在过去的5年时间里,哈默国际工作网络的专家组足迹已踏遍中国的大江南北,并先后与国内近20家饲料企业建立合作关系。他们将先进的技术和管理理念引入中国,在一定程度上加速了中国养猪业的发展。那么,这些国外动物营养专家如何看待中国的养猪业?在全球逐步一体化的今天,我们在产品技术的研发方面应该做哪些准备?面对动物疫情频发而食品安全呼声愈加强烈的矛盾,我们又该如何解决这一问题?《中国畜牧杂志》携您一起走近哈默,再次审视中国养猪业。     

品质保证:玉米差异性的难题

许多动物养殖者和饲料生产者常常忽略玉米作为一种饲料原料的不同产地和生长条件,误其在营养价值方面仅有微小区别,然而事实并非如此。玉米营养价值的差异性是当前摆在饲料生产商面前的主要难题,主要集中在蛋白质和氨基酸含量方面,尤其是赖氨酸含量。然而笔者历经两年时间,从世     

白三叶草营养动态的研究

影响白三叶草营养成分的因素有品种，不同收割时期，不同部位─—茎和叶，不同海拔高度等。本文就影响白三叶草营养价值的各种因素进行了探讨。     

饲料及其原料中尿素检测方法的研究进展

本文就近年来国内外报道饲料及其原料中尿素检测方法的相关原理及应用进行综述,并对建立健全统一的尿素检测体系提出建议。     

深入推进首都签约兽医工作的思考

首都签约兽医工作是首都官方兽医的配套制度和工作体系的有机组成部分,按照北京市布署,房山区认真调研、部署推进。本文对签约兽医模式与协检员模式进行了简单的比较,对推进首都签约兽医运行机制的关键点进行了分析,并提出了建议:分类管理"专职"和"兼职"签约兽医,细化"签约",建立并逐步强化签约兽医责任追溯机制,争取各级财政落实专职签约兽医福利待遇和兼职签约兽医发放津贴等。     

Pharmacokinetics of cefquinome in tilapia (Oreochromis niloticus) after a single intramuscular or intraperitoneal administration

The pharmacokinetics of cefquinome was studied in plasma after a single dose (10 mg/kg) of intramuscular (i.m.) or intraperitoneal (i.p.) administration to tilapia (Oreochromis niloticus) in freshwater at 30 °C. Ten fish per sampling point were examined after treatment. The data were fitted to two‐compartment open models following both routes of administration. The estimates of total body clearance (CL/F), volume of distribution (Vd/F), and absorption half‐life (T_1/2ka) were 0.049 and 0.037 L/h/kg, 0.41 and 0.33 L/kg, and 0.028 and 0.035 h following i.m. and i.p. administration, respectively. After i.m. injection, the elimination half‐life (T_1?2β) was calculated to be 5.81 h, the maximum plasma concentration (C_max) to be 49.40 μg/mL, the time to peak plasma cefquinome concentration (T_max) to be 0.14 h, and the area under the plasma concentration–time curve (AUC) to be 204.6 μg h/mL. Following i.p. administration, the corresponding estimates were 6.05 h, 44.39 μg/mL, 0.17 h and 267.8 μg h/mL. The minimum inhibitory concentrations of cefquinome, determined for 30 strains of Streptococcus agalactiae isolated from diseased tilapia, ranged from 0.015 to 0.12 μg/mL. Results from these studies support that 10 mg cefquinome/kg body weight daily could be expected to control tilapia bacterial pathogens inhibited in vitro by a minimal inhibitory concentration value of ≤2 μg/mL.     

Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase

Mammalian target of rapamycin (mTOR) signaling is one of the main signaling pathways controlling protein synthesis. Leucine treatment upregulates mTOR signaling, which enhances protein synthesis; however, the mechanisms are not well understood. Herein, treatment of C2C12 myoblast cells with leucine enhanced the phosphorylation of mTOR and ribosomal protein S6 kinase. Leucine treatment also decreased the adenosine monophosphate/ATP ratio in myoblasts by 36.4 +/- 9.1% (P < 0.05) and reduced the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) alpha subunit at Thr172 (28.6 +/- 4.9% reduction, P < 0.05) and inhibited AMPK activity (43.6 +/- 3.5% reduction, P < 0.05). In addition, leucine increased the phosphorylation of mTOR at Ser2448 by 63.5 +/- 10.0% (P < 0.05) and protein synthesis by 30.6 +/- 6.1% (P < 0.05). Applying 5-aminoimidazole-4-carbox-amide 1-beta-d-ribonucleoside, an activator of AMPK, abolished the stimulation of mTOR signaling by leucine, showing that AMPK negatively controls mTOR signaling. To further show the role of AMPK in mTOR signaling, myoblasts expressing a dominant negative AMPKalpha subunit were employed. Negative myoblasts had very low AMPK activity. The activation of mTOR induced by leucine in these cells was abated, showing that AMPK contributed to mTOR activation. In conclusion, leucine stimulates mTOR signaling in part through AMPK inhibition. This study implicates AMPK as an important target for nutritional management to enhance mTOR signaling and protein synthesis in muscle cells, thereby increasing muscle growth.     

Immunoadjuvant effects of hemagglutinating virus of Japan envelope (HVJ-E) on the inactivated H9 subtype avian influenza virus vaccine

Avian influenza viruses (AIV) of the H9 subtype cause serious health problems in chickens, resulting in great economic losses to the poultry industry worldwide. The killed vaccine (KV) against H9 subtype AIV has been widely used in China since 1998 but has been linked with side effects in chickens and only partial protection. A few studies have demonstrated the immunostimulatory effects of the hemagglutinating virus of Japan envelope (HVJ-E) in cancer therapy. In this study, the adjuvant efficacy and the protective effects of HVJ-E, in combination with H9N2 AI KV against AIV were evaluated. The maturation of murine dendritic cells treated by HVJ-E was verified by FACS in the current experiment, then the antibody hemagglutination inhibition (HI) titers and cytokines and the post-challenge virological profiles (oropharyngeal and cloacal virus shedding) were investigated to define the immune responses in chickens. Our findings indicate that HVJ-E could induce dendritic cell (DC) maturation in mice. Injection of HVJ-E in chickens resulted in raised levels of IFN-β and IFN-γ being present in sera suggesting a stimulatory effect in these animals. The antibody responses to AIV of chickens inoculated with HVJ-E adjuvanted killed H9-AIV were higher than those of chickens inoculated with oil adjuvanted H9-HIV. Furthermore, although inoculation of either HVJ-E or oil adjuvanted AIV reduced virus shedding following challenge, compared to controls, HVJ-E adjuvanted AIV was more effective in reducing shedding than oil adjuvant.